Child's sudden death rocks the gene therapy field

The death has sent concern and uncertainty rippling through labs and companies along with rare disease groups.

December 20, 2025 Check out STAT+

Sponsored By

We have a special deal this holiday season: Get 25% off your first year of STAT+. And don't miss the latest installments of our American Science, Shattered series below. Thanks for reading.

Lucy Lu for STAT As dangerous eugenic ideas spread, NIH falls silent Cuts to the Human Genome Research Institute's communication offices left a bioethics vacuum. Part 9 of 'American Science, Shattered' By Megan Molteni and Anil Oza Maria Fabrizio for STAT STAT+ | Child's sudden death unnerves a promising area of gene therapy research Researchers fear a broad risk for any virus genetically designed to penetrate the blood-brain barrier after no hint of issues prior to Capsida trial death. By Jason Mast Mike Reddy for STAT STAT+ | Data on Humana's clinics looked dismal. Then its corporate research machine got to work Insiders say research reports needed to align with marketing message: Medicare Advantage saves money, produces better results than traditional Medicare. By Casey Ross and Tara Bannow STAT+ | Amid talk of a brain drain, some scientists leave U.S. behind Dutch postdoc turned U.S. scientist returns to Europe for better research opportunities. Part 8 of 'American Science, Shattered' looks at brain drain. By Andrew Joseph CDC awards grant to controversial Danish researchers with ties to top FDA official The $1.6 million grant, to study the hepatitis B birth dose in Guinea-Bissau, has concerned experts who say the study design may be unethical. By Lizzy Lawrence and Helen Branswell For some with bipolar disorder, manic episodes are magnified for all to see online Delusional, sometimes hurtful remarks by people with bipolar disorder can leave "a lot of cleaning up to do" in the era of social media. By Eric Berger STAT+ | FDA voucher program has become vehicle for political interference in drug review decisions, staffers say The "Commissioner's National Priority Review Program" is seen as having fast-tracked reviews but at the expense of career scientists' expertise. By Lizzy Lawrence Opinion: Why Denmark's vaccine schedule works for Denmark — but not for the United States When it comes to vaccines, Denmark and the U.S. have fundamentally different health care systems, disease burdens, and policy priorities. By Jake Scott STAT+ | RFK Jr., unconstrained by Congress, presses ahead to reshape health care Kennedy has seemingly faced few constraints as he focuses on MAHA, restructures his health department, and builds his power. By Chelsea Cirruzzo

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Weekend Reads? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser